ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Towards equitable AI in oncology

Viswanathan, Vidya Sankar; Parmar, Vani; Madabhushi, Anant*
Nature Reviews. Clinical Oncology2024-8DOI: 10.1038/s41571-024-00909-8
3被引6阅读
引用收藏
分享

摘要

Artificial intelligence (AI) stands at the threshold of revolutionizing clinical oncology, with considerable potential to improve early cancer detection and risk assessment, and to enable more accurate personalized treatment recommendations. However, a notable imbalance exists in the distribution of the benefits of AI, which disproportionately favour those living in specific geographical locations and in specific populations. In this Perspective, we discuss the need to foster the development of equitable AI tools that are both accurate in and accessible to a diverse range of patient populations, including those in low-income to middle-income countries. We also discuss some of the challenges and potential solutions in attaining equitable AI, including addressing the historically limited representation of diverse populations in existing clinical datasets and the use of inadequate clinical validation methods. Additionally, we focus on extant sources of inequity including the type of model approach (such as deep learning, and feature engineering-based methods), the implications of dataset curation strategies, the need for rigorous validation across a variety of populations and settings, and the risk of introducing contextual bias that comes with developing tools predominantly in high-income countries. Artificial intelligence (AI) has the potential to dramatically change several aspects of oncology including diagnosis, early detection and treatment-related decision making. However, many of the underlying algorithms have been or are being trained on datasets that do not necessarily reflect the diversity of the target population. For this, and other reasons, many AI tools might not be suitable for application in less economically developed countries and/or in patients of certain ethnicities. In this Perspective, the authors discuss possible sources of inequity in AI development, and how to ensure the development and implementation of equitable AI tools for use in patients with cancer.

学科与关键词

关键词
ARTIFICIAL-INTELLIGENCEHEALTHMEDICINERACEBIASALGORITHMSGUIDELINESETHNICITYSURVIVALFEATURES
相关
加载中…
  • Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care
    Corti, Chiara*; Cobanaj, Marisa; Dee, Edward C.; Criscitiello, Carmen; Tolaney, Sara M.; Celi, Leo A.; Curigliano, GiuseppeCancer Treatment Reviews, 2023, 112: 102498.被引 26
  • The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review
    Istasy, Paul; Lee, Wen Shen; Iansavichene, Alla; Upshur, Ross; Gyawali, Bishal; Burkell, Jacquelyn; Sadikovic, Bekim; Lazo-Langner, Alejandro; Chin-Yee, Benjamin*JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24(11): e39748.被引 25
  • Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow
    Cobanaj, Marisa; Corti, Chiara*; Dee, Edward C.; McCullum, Lucas; Boldrini, Laura; Schlam, Ilana; Tolaney, Sara M.; Celi, Leo A.; Curigliano, Giuseppe; Criscitiello, CarmenEuropean Journal of Cancer, 2024, 198: 113504.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Reviews. Clinical Oncology
发表日期
2024-08
卷期
第 21 卷, 第 8 期
页码
628-637
DOI
10.1038/s41571-024-00909-8
语言
ENGLISH
成果收录
SCIE

作者

  • V

    Viswanathan, Vidya Sankar (第一作者)

  • P

    Parmar, Vani

查看全部 3 位作者收起作者
  • M

    Madabhushi, Anant (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417